Jinshui Tan

发表

Multiple Omics Analysis Reveals E2F5 Predict Prognostic Biomarker in Diffuse Large B-Cell Lymphoma

Zhen Lu, Mengya Zhong, Jie Zha, 2021 .

Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells

Mengya Zhong, Haijun Zhao, Manman Deng, 2022, Experimental Hematology & Oncology.

Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis

Mengya Zhong, Hai-gang Lu, Huiwen Zhou, 2021, Cancer cell international.

Stratification and therapeutic potential of ELL in cytogenetic normal acute myeloid leukemia.

Huiyang Zhou, Mengya Zhong, Qian Lai, 2022, Gene.

Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling

Huiyang Zhou, Mengya Zhong, Zhijuan Lin, 2022, Journal of Cancer Research and Clinical Oncology.

Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway

Mengya Zhong, Chen Xie, Jiewen Huang, 2022, Pharmaceuticals.

Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia.

Huiyang Zhou, Z. Fang, Mengya Zhong, 2022, Cancer letters.

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma

L. Fan, Mengya Zhong, Bing Xu, 2021, Frontiers in Oncology.

Therapeutic Interaction of Apatinib and Chidamide in T-cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis

Mengya Zhong, Bing Xu, Hui Zhou, 2021, Journal of personalized medicine.

Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway

Mengya Zhong, G. Fu, Jiewen Huang, 2023, Discover Oncology.

Anlotinib suppresses the DNA damage response by disrupting SETD1A and inducing p53-dependent apoptosis in Transformed Follicular Lymphoma

Mengya Zhong, Jie Zha, Genhong Li, 2024, International Journal of Medical Sciences.

The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression

Haijun Zhao, Manman Deng, X. Fang, 2023, Scientific reports.